Drugs / ATG
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06365437 Comparator | Jun 2021 → Dec 2024 | — | ITB-Med LLC | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ATG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06365437 ↗ |
| Known as | rATG | “Anti-thymocyte Globulin (rATG)” NCT06365437 ↗ |
| Modality | Protein / enzyme biologic | “Anti-thymocyte Globulin (rATG)” NCT06365437 ↗ |